PLD
56
-5
FDX
44
-2
ADI
51
-3
AEE
64
3
TSN
42
3
DRI
57
-3
DHR
41
2
FCX
57
-2
OI
38
-5
PSX
50
3
EW
46
3
LEN
57
-4
F
54
-6
GOOG
57
2
EXPD
48
-5
LH
45
-3
URI
73
5
VTR
55
8
HCA
48
2
WYNN
38
-3
PLD
56
-5
FDX
44
-2
ADI
51
-3
AEE
64
3
TSN
42
3
DRI
57
-3
DHR
41
2
FCX
57
-2
OI
38
-5
PSX
50
3
EW
46
3
LEN
57
-4
F
54
-6
GOOG
57
2
EXPD
48
-5
LH
45
-3
URI
73
5
VTR
55
8
HCA
48
2
WYNN
38
-3
Financhill
Back

Regencell Bioscience Holdings 10K Form

Sell
30

RGC
Regencell Bioscience Holdings

Last Price:
5.75
Seasonality Move:
-1.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RGC News And Ratings

See the #1 stock for the next 7 days that we like better than RGC

RGC Financial Statistics

Sales & Book Value

Annual Sales: $3.16B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.63
Price / Book: 9.66

Profitability

EPS (TTM): -0.33000
Net Income (TTM): $-4.3M
Gross Margin: $1.97B
Return on Equity: 0%
Return on Assets: 0%

Regencell Bioscience Holdings Earnings Forecast

Key Regencell Bioscience Holdings Financial Ratios

  • The Gross Profit Margin over the past 13 years for RGC is 62.33%.
  • The Selling, General & Administrative Expenses for RGC have been equal to 16.23% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 8 years.

Regencell Bioscience Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RGC
Website: regencellbioscience.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RGC Technical Analysis vs Fundamental Analysis

Sell
30
Regencell Bioscience Holdings (RGC) is a Sell

Is Regencell Bioscience Holdings a Buy or a Sell?